References
- Nordlund JJ, Boissy RE, Hearing VJ et al. The Pigmentary System: Physiology and Pathophysiology. Blackwell Scientific Publishers, Oxford, UK 1–1245 (2006).
- Nordlund JJ. The Epidermal Melanin Unit: an expanded version called the KLM Unit. Dermatol. Clin. (2007) (In Press).
- Nordlund J, Grimes P, Ortonne J. The safety of hydroquinone. J. Eur. Acad. Dermatol. Venereol.20, 781–787 (2006).
- US FDA. Skin Bleaching Drug Products For Over-the-Counter Human Use; Proposed Rule. Volume 71. Administration FDA (Ed.). Federal Register, USA 51146–51156 (2007).
- Penney KB, Smith CJ, Allen JC. Depigmenting action of hydroquinone depends on disruption of fundamental cell processes. J. Invest. Dermatol.82, 308–310 (1984).
- Cummings M, Nordlund JJ. Chemical leukoderma: fact or fancy. Amer. J. Contact Derm.6, 122–127 (1995).
- Pifer JW, Hearne FT, Friedlander BR, McDonough JR. Mortality study of men employed at a large chemical plant, 1972 through 1982. J. Occup. Med.28, 438–444 (1986).
- Pifer JW, Hearne FT, Swanson FA et al. Mortality study of employees engaged in the manufacture and use of hydroquinone. Int. Arch.Occupational Env. Health67, 267–280 (1995).